期刊文献+

本院2011-2013年儿科门诊手足口病处方评价分析 被引量:5

The Evalution and Analysis of Hand-Foot-Mouth Disease Prescription in the Outpatient of Our Hospital from 2011 to 2013
下载PDF
导出
摘要 目的:了解本院儿科门诊手足口病的发病情况及用药特点,为预防、治疗、控制手足口病提供科学依据。方法:随机抽取本院2011年1月-2013年12月儿科门诊处方24 000张(8000张/年,2000张/季度),对确诊为手足口病的处方进行评价分析。结果:2011-2013年本院儿科门诊手足口病例数占儿科门诊总病例数的比例分别为:2.95%、3.21%、3.70%,6岁及其以下的儿童发病人数为744例,占处方总数的94.30%,3岁及其以下患儿发病比例为66.20%,发病高峰期为4-6月份;本院儿科门诊治疗手足口病主要以抗病毒治疗为主,继发细菌感染时在临床药师的指导和干预下合理使用抗菌药物,根据患儿病情合理联合使用维生素、免疫增强剂、糖皮质激素等药物。结论:本院儿科门诊手足口病发病率呈逐年上升趋势,发病有明显的季节性特点,本院儿科门诊治疗手足口病以抗病毒治疗为主,在临床药师的指导干预下,合理规范化使用抗菌药物,保证了儿童用药安全。 Objective: To understand the incidence and feature in choosing drugs of hand-foot-mouth disease in the outpatient of our hospital,in order to provide a scientific basis for prevention care and control for hand-foot-mouth disease. Method:24 000 prescriptions(8000 prescriptions/year,2000 prescriptions/quarter) of pediatric outpatient were taken randomly from January 2011 to December 2013 in our hospital, the part of them were hand-foot-mouth diseases prescription, which should be evaluated.Result: From 2011 to 2013, the number of cases in proportion to the total number cases of the outpatient in our hospital were respectively 2.95%,3.21%,and 3.70%.The number of child mortality under the age of 6 were 744 cases, which accounted for 94.30% of the total prescriptions, and children under the age of 3 accounted for 66.20%, and the morbidity peak was from May to July.In our hospital, we mostly based on antiviral treatment to treat hand-foot-mouth disease in the outpatient.Under the guidance and intervention of clinical pharmacists when secondary bacterial infection. According to the illness of children, we used reasonable combination of vitamins, immune enhancer, corticosteroids and other drugs. Conclusion: There is an upward trend in incidence of hand-footmouth diseases in the outpatient of our hospital, the disease has obvious seasonal characteristic, our hospital mostly based on antiviral treatment to treat hand-foot-mouth disease in the outpatient.Under the guidance and intervention of clinical pharmacists, we use antimicrobial agents rationally and ensure the drug safety of children.
出处 《中国医学创新》 CAS 2015年第8期60-62,共3页 Medical Innovation of China
关键词 手足口病 抗病毒药物 抗菌药物 处方评价 Foot and mouth disease Antiviral drugs Antimicrobial agents Prescription evaluation
  • 相关文献

参考文献19

二级参考文献122

共引文献162

同被引文献67

  • 1薛源,刘桦.我院门诊退药处方分析及干预[J].中国医疗前沿,2012,7(15):62-63. 被引量:6
  • 2中华人民共和国卫生部.手足口病诊疗指南[S].北京:人民卫生出版社,2010.
  • 3Lowenthal A,Camacho B V,Lowenthal S,et al.Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease[J].Am J Cardiol,2012,109(6):866-872.
  • 4Jan S L,Lin S J,Fu Y C,et al.Plasma B-type natriuretic peptide study in children with severe enterovirus 71 infection:a pilot study[J].Int J Infect Dis,2013,17(12):e1166-1171.
  • 5Tylor C J,Roalfe A K,Iles R,et al.The potential role of NT-pro BNP in screening for and predicting prognosis in heart failure:a survival analysis[J].BMJ Open,2014,4(4):e4675.
  • 6Noveanu M,Brcidthardt T,Potocki M,et al.Direct comparison of serial B-type natriuretie peptide and NT-pro BNPlevels for prediction of short-and long term outcome in acute decompensated heartfailure[J].Crit Care,2011,15(1):R1.
  • 7De Geer L,Fredrikson M,Oscarsson A.Amino-terminal probrain natfiuretic peptide as a predictor of outcome in patients admitted to intensive care.A prospective observational study[J].Eur J Anaesthesiol,2012,29(6):275-279.
  • 8手足口病预防控制指南(2008年版)[J].中国实用乡村医生杂志,2008,15(6):46-48. 被引量:34
  • 9杨小燕,肖久长.血清肌钙蛋白I检测对婴幼儿手足口病心肌损害的临床意义[J].实验与检验医学,2009,27(6):677-677. 被引量:5
  • 10王翊飞,吴建祥.重型颅脑外伤合并急性肾功能损伤危险因素分析[J].河北医科大学学报,2010,31(7):759-761. 被引量:2

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部